Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
- 1 January 1989
- journal article
- research article
- Published by Wiley
- Vol. 28 (S2) , 115S-131S
- https://doi.org/10.1111/j.1365-2125.1989.tb03587.x
Abstract
1. Seven drugs (captopril, zofenopril, enalapril, ramipril, lisinopril, fosinopril, and SQ 29,852) were compared in vitro in homogenates of aorta, brain, heart, lung, and kidney and in sera of spontaneously hypertensive rats (SHR) both with respect to potencies of their active moieties as inhibitors of angiotensin-converting enzyme (ACE), and, where applicable, rates of hydrolysis of their prodrug ester functions. 2. In ex vivo dose-response and time-course studies, the inhibitory effects of the seven drugs on tissue ACEs and their relative distributions to SHR tissues were compared following oral administration. 3. The relative potencies of the inhibitory moieties of the drugs (in parentheses) and the normalized 'equiactive' oral doses employed for time-course studies were: SQ 29,852 (1.0), 100 mg kg-1; captopril (3.5), 30 mg kg-1; enalapril (12), 20 mg kg-1; fosinopril (13), 25 mg kg-1; zofenopril (20), 10 mg kg-1; lisinopril (24), 10 mg kg-1; and ramipril (51), 5 mg kg-1. 4. Following oral administration of the drugs to SHR, the degree and duration of ACE inhibition in aorta and lung correlated with the antihypertensive actions, with ramipril, lisinopril, and zofenopril producing effects of the greatest magnitude and duration. 5. Ramipril and enalapril did not inhibit brain ACE ex vivo; captopril and zofenopril had modest but short-lasting effects; and fosinopril, lisinopril, and SQ 29,852 had long-lasting inhibitory actions, which, with the latter two, were delayed in onset. 6. All of the drugs produced significant inhibition of kidney ACE, with ramipril and fosinopril having somewhat weaker effects, perhaps due to biliary routes of excretion. 7. Captopril, fosinopril, and particularly zofenopril inhibited cardiac ACE ex vivo with degrees and durations that were marked compared with those of the other drugs; preliminary studies with isolated hearts suggest a possible relationship between inhibition of cardiac ACE and preservation of cardiac function subsequent to ischaemia.Keywords
This publication has 56 references indexed in Scilit:
- Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitorBiochemical and Biophysical Research Communications, 1989
- Angiotensin converting enzyme inhibitors. II. Clinical useAmerican Heart Journal, 1988
- Converting-Enzyme Inhibitors in the Treatment of HypertensionNew England Journal of Medicine, 1988
- Angiotensin converting enzyme inhibitors. I. PharmacologyAmerican Heart Journal, 1988
- Angiotensin-Converting Enzyme InhibitorsClinical Pharmacokinetics, 1988
- Comparison of Captopril and Enalapril in Patients with Severe Chronic Heart FailureNew England Journal of Medicine, 1986
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Persistent Tissue Converting Enzyme Inhibition Following Chronic Treatment with Hoe498 and MK421 in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1985
- Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.Circulation, 1982
- Untersuchungen am überlebenden SäugethierherzenPflügers Archiv - European Journal of Physiology, 1895